Abstract:Hossein Zare, 1, 2 Sepideh Ahmadi, 3, 4 Amir Ghasemi, 5 Mohammad Ghanbari, 6 Navid Rabiee, 7 Mojtaba Bagherzadeh, 7 Mahdi Karimi, 8– 11 Thomas J Webster, 12 Michael R Hamblin, 13 Ebrahim Mostafavi 12, 14, 15 1 Advances Nanobiotechnology and Nanomedicine Research Group (ANNRG), Iran University of Medical Sciences, Tehran, Iran; 2 Biomaterials Group, Materials Science and Engineering Department, Iran University of Science and Technology, Tehran, Iran; 3 Student Research Committee, Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 4 Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 5 Department of Engineering, Durham University, Durham, DH1 3LE, United Kingdom; 6 School of Metallurgy and Materials Engineering, University of Tehran, Tehran, Iran; 7 Department of Chemistry, Sharif University of Technology, Tehran, Iran; 8 Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran; 9 Department of Medical Nanotechnology, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran; 10 Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran; 11 Research Center for Science and Technology in Medicine, Tehran University of Medical Sciences, Tehran, MA, Iran; 12 Applied Biotechnology Research Centre, Tehran Medical Science, Islamic Azad University, Tehran, MA, Iran; 13 Laser Research Centre, Faculty of Health Science, University of Johannesburg, Doornfontein, 2028, South Africa; 14 Stanford Cardiovascular Institute, Stanford, CA, USA; 15 Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA Correspondence: Ebrahim Mostafavi Stanford Cardiovascular Institute, Stanford University School of Medicine, Biomedical Innovation Building, 240 Pasteur Dr, Palo Alto, CA, 94304, USA Email ebimsv@stanford.edu Michael R Hamblin Laser Research Centre, Faculty of Health Science, University of Johannesburg, Doornfontein, 2028, South Africa Email hamblin.lab@gmail.com The unique properties of carbon nanotubes (CNTs) (such as their high surface to volume ratios, enhanced conductivity and strength, biocompatibility, ease of functionalization, optical properties, etc.) have led to their consideration to serve as novel drug and gene delivery carriers. CNTs are effectively taken up by many different cell types through several mechanisms. CNTs have acted as carriers of anticancer molecules (including docetaxel (DTX), doxorubicin (DOX), methotrexate (MTX), paclitaxel (PTX), and gemcitabine (GEM)), anti-inflammatory drugs, osteogenic dexamethasone (DEX) steroids, etc. In addition, the unique optical properties of CNTs have led to their use in a number of platforms for improved photo-therapy. Further, the easy surface functionalization of CNTs has prompted their use to deliver different genes, such as plasmid DNA (PDNA), micro-RNA (miRNA), and small interfering RNA (siRNA) as gene delivery vectors for various diseases such as cancers. However, despite all of these promises, the most important continuous concerns raised by scientists reside in CNT nanotoxicology and the environmental effects of CNTs, mostly because of their non-biodegradable state. Despite a lack of widespread FDA approval, CNTs have been studied for decades and plenty of in vivo and in vitro reports have been published, which are reviewed here. Lastly, this review covers the future research necessary for the field of CNT medicine to grow even further. Keywords: drug delivery, gene delivery, carbon nanotube, precision medicine

Single-Walled (Magnetic) Carbon Nanotubes in a Pectin Matrix in the Design of an Allantoin Delivery System

Non‐Covalent Functionalization of Magnetic Carbon Nanotubes with Fmoc Amino Acid‐Modified Polyethylene Glycol

Magnetically Controllable Polymer Nanotubes from a Cyclized Crosslinker for Site-Specific Delivery of Doxorubicin

Preparation, Loading, and Cytotoxicity Analysis of Polymer Nanotubes from an Ethylene Glycol Dimethacrylate Homopolymer in Comparison to Multi‐walled Carbon Nanotubes

Evaluation of 3D Hybrid Alginate/Single Wall Carbon Nanotube Tissue Scaffolds in Terms of Process and Cytocompatibility

Preparation of Carbon Nanotube Bioconjugates for Biomedical Applications

Mussel-inspired PEGylated Carbon Nanotubes: Biocompatibility Evaluation and Drug Delivery Applications.

Magnetic Nanostructure-Loaded Bicontinuous Nanospheres Support Multicargo Intracellular Delivery and Oxidation-Responsive Morphological Transitions

Synthesis of carboxymethyl Xanthan/ double-walled carbon nanotube hybrid hydrogel nanocomposite for transdermal release of drug

Molecular dynamics simulation of non-covalent single-walled carbon nanotube functionalization with surfactant peptides

Molecular dynamics investigation on synthesis of a pH- and temperature-sensitive carbon nanotube loaded with doxorubicin

A Facile, One-Step Nanocarbon Functionalization For Biomedical Applications

Drug delivery with carbon nanotubes for in vivo cancer treatment

Noncovalent Surface Modification of Carbon Nanotubes for Solubility in Organic Solvents

Effects of Single-Walled Carbon Nanotubes on the Functions of Plasma Proteins and Potentials in Vascular Prostheses.

Carbon Nanotubes: Smart Drug/Gene Delivery Carriers

Fabrication, Characterization, and Biocompatibility of Single-Walled Carbon Nanotube-Reinforced Alginate Composite Scaffolds Manufactured Using Freeform Fabrication Technique.

Polysaccharide Functionalized Single Walled Carbon Nanotubes as Nanocarriers for Delivery of Curcumin in Lung Cancer Cells

Sol–gel synthesis of Ag-doped titania-coated carbon nanotubes and study their biomedical applications

Carbon and Core Shell like Molecular Nanostructures in Cancer diagnosis and Therapy

Synthesis, characterization and drug release application of carbon nanotube-polymer nanosphere composites